MedTrace Logo

A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.

NCT04365634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2020-04-28

No results posted yet for this study

Summary

In the single-centered, retrospective study, 306 hospital patients (including 129 diabetes and 177 non-diabetes patients) confirmed with SARS-CoV-2 infection were enrolled in Tongji Hospital, Wuhan, China. Clinical characteristics including clinical manifestation, laboratory parameters, lung CT features and clinical outcomes were compared between diabetes and non-diabetes patients. The prediction factors were analyzed for mortality of COVID-19 by univariate and multivariate analysis.

Conditions

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Meifang Han, Professor · Tongji Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-02
Primary Completion
2020-03-15
Completion
2020-04-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04365634 on ClinicalTrials.gov